Published in J Virol on November 01, 1991
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol (1993) 6.11
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J Virol (1992) 5.85
Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J Virol (1993) 3.37
Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J Virol (1993) 3.12
Subcellular localization of the Vif protein of human immunodeficiency virus type 1. J Virol (1994) 2.35
Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J Virol (1995) 2.35
The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J Virol (1995) 2.25
Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J Virol (1995) 1.97
Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. J Virol (1993) 1.88
Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J Virol (1998) 1.54
Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity. J Virol (1994) 1.42
vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. J Virol (1996) 1.22
HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle. J Clin Invest (1994) 1.18
Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors. Microbiol Mol Biol Rev (2009) 1.12
Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4. J Virol (1996) 1.10
Context-dependent role of human immunodeficiency virus type 1 auxiliary genes in the establishment of chronic virus producers. J Virol (1993) 1.06
Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo. J Virol (1995) 1.06
Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles. J Virol (1996) 0.96
Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro. J Virol (1997) 0.94
Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7. PLoS One (2012) 0.89
Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells. J Virol (1995) 0.88
Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A. J Virol (2008) 0.85
Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag. J Virol (2001) 0.83
Peptide inhibitors of HIV-1 protease and viral infection of peripheral blood lymphocytes based on HIV-1 Vif. Proc Natl Acad Sci U S A (1998) 0.83
The RRE of human immunodeficiency virus type 1 contributes to cell-type-specific viral tropism. J Virol (1993) 0.81
Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science (1984) 32.33
Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (1986) 10.62
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science (1984) 10.40
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science (1984) 10.38
Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J Virol (1989) 9.37
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell (1987) 9.29
CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. Cancer (1965) 8.54
The HIV 'A' (sor) gene product is essential for virus infectivity. Nature (1987) 7.51
Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet (1986) 7.09
Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood (1980) 6.17
The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science (1987) 6.16
AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science (1986) 5.58
Genomic diversity of human T-lymphotropic virus type III (HTLV-III). Science (1985) 5.33
Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. Proc Natl Acad Sci U S A (1985) 5.10
Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol (1988) 4.96
Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J Virol (1990) 4.85
Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects. Science (1986) 4.17
Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science (1986) 4.04
Biologically diverse molecular variants within a single HIV-1 isolate. Nature (1988) 3.80
The P30 movement protein of tobacco mosaic virus is a single-strand nucleic acid binding protein. Cell (1990) 3.70
Differential ability of human immunodeficiency virus isolates to productively infect human cells. J Immunol (1987) 3.19
Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci U S A (1990) 3.18
Replication and pathogenesis of the AIDS virus. J Acquir Immune Defic Syndr (1988) 2.50
Type-restricted neutralization of molecular clones of human immunodeficiency virus. Science (1988) 2.31
Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual. J Virol (1988) 2.24
Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection. Science (1988) 2.12
Isolation frequency and growth properties of HIV-variants: multiple simultaneous variants in a patient demonstrated by molecular cloning. J Med Virol (1987) 1.92
In vitro generation of an HTLV-III variant by neutralizing antibody. J Immunol (1986) 1.91
West African HIV-2-related human retrovirus with attenuated cytopathicity. Science (1988) 1.86
A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. J Virol (1991) 1.72
Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression. Science (1988) 1.72
Interaction of a noncytopathic human immunodeficiency virus type 1 (HIV-1) with target cells: efficient virus entry followed by delayed expression of its RNA and protein. Virology (1990) 1.33
Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis. J Virol (1990) 1.32
Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection. Proc Natl Acad Sci U S A (1988) 1.19
Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates. J Virol (1990) 1.19
Retroviral etiology of the acquired immune deficiency syndrome (AIDS). AIDS Res (1986) 0.94
Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village. AIDS Res (1986) 0.88
Characteristics of HIV infection and pathogenesis. Biochim Biophys Acta (1989) 0.86
Low-cytopathic infectious clone of human immunodeficiency virus type I (HIV-I). FEBS Lett (1988) 0.81
Assumptions of AIDS inquiry challenged. Nature (1990) 0.78
Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1. J Virol (1993) 3.12
Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med (1992) 2.48
Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes. Physiol Genomics (2006) 2.38
Differences in cytopathogenicity and host cell range among infectious molecular clones of human immunodeficiency virus type 1 simultaneously isolated from an individual. J Virol (1988) 2.24
Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol (2003) 2.11
Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J Virol (1995) 1.97
Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus. J Virol (1987) 1.85
Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. J Virol (1987) 1.84
In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest (1993) 1.80
Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells. J Virol (1993) 1.57
Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist. Science (1991) 1.55
Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity. J Virol (1994) 1.42
Transfer of Epstein-Barr virus receptors to receptor-negative cells permits virus penetration and antigen expression. Proc Natl Acad Sci U S A (1980) 1.38
Results of air pressure enema reduction of intussusception: 6,396 cases in 13 years. J Pediatr Surg (1986) 1.34
Interaction of a noncytopathic human immunodeficiency virus type 1 (HIV-1) with target cells: efficient virus entry followed by delayed expression of its RNA and protein. Virology (1990) 1.33
Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes. J Virol (2001) 1.28
Transfection of DNA into adherent cells by DEAE-dextran/DMSO method increases drastically if the cells are removed from surface and treated in suspension. Nucleic Acids Res (1989) 1.27
A human T-cell line resistant to cytopathic effects of the human immunodeficiency virus (HIV). Virology (1987) 1.26
An efficient method for reassembly of fusogenic Sendai virus envelopes after solubilization of intact virions with Triton X-100. FEBS Lett (1978) 1.25
Quantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenching. FEBS Lett (1988) 1.24
vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. J Virol (1996) 1.22
Susceptibility of human glial cells to infection with human immunodeficiency virus (HIV). FEBS Lett (1987) 1.19
Infection of macrophages with lymphotropic human immunodeficiency virus type 1 can be arrested after viral DNA synthesis. J Virol (1993) 1.19
Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates. J Virol (1990) 1.19
Role of Ca++ in virus-induced membrane fusion. Ca++ accumulation and ultrastructural changes induced by Sendai virus in chicken erythrocytes. J Cell Biol (1978) 1.10
Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes. Mol Cell Biol (1986) 1.07
Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion. Protein Eng (2001) 1.07
Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo. J Virol (1995) 1.06
Observation of a charged charmoniumlike structure in e+ e- → π+ π- J/ψ at sqrt[s] = 4.26 GeV. Phys Rev Lett (2013) 1.05
Immortalization of human T lymphocytes after transfection of Epstein-Barr virus DNA. Science (1986) 1.04
Induction of rapid and extensive beta-chemokine synthesis in macrophages by human immunodeficiency virus type 1 and gp120, independently of their coreceptor phenotype. J Virol (2001) 1.02
Implantation of the isolated human erythrocyte anion channel into plasma membranes of Friend erythroleukemic cells by use of Sendai virus envelopes. Proc Natl Acad Sci U S A (1979) 1.02
Antibodies to HTLV-III/LAV in Venezuelan patients with acute malarial infections. N Engl J Med (1986) 1.01
Expression of Epstein-Barr virus (EBV) DNA and cloned DNA fragments in human lymphocytes following Sendai virus envelope-mediated gene transfer. Proc Natl Acad Sci U S A (1984) 1.01
Observation of electron-antineutrino disappearance at Daya Bay. Phys Rev Lett (2012) 1.00
Alteration of lymphocyte surface properties by insertion of foreign functional components of plasma membrane. Proc Natl Acad Sci U S A (1980) 1.00
Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome. Arch Pathol Lab Med (1985) 0.99
Establishment of retrovirus-, Epstein-Barr virus-positive B-lymphoblastoid cell lines derived from individuals at risk for acquired immune deficiency syndrome (AIDS). AIDS Res (1986) 0.99
Superoxide-mediated early oxidation and activation of ASK1 are important for initiating methylglyoxal-induced apoptosis process. Free Radic Biol Med (2001) 0.99
Virus-cell membrane fusion does not predict efficient infection of alveolar macrophages by human immunodeficiency virus type 1 (HIV-1). Virology (1992) 0.98
Discovery and characterization of an HIV-1 Tat antagonist. Biochem Soc Trans (1992) 0.97
Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications. J Med Virol (1986) 0.97
Infection of normal human epithelial cells by Epstein-Barr virus. Science (1983) 0.96
Expression of an anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin in a mutant CHO cell line. Protein Expr Purif (2000) 0.95
Regulated expression of human immunodeficiency virus type 1 in human glial cells: induction of dormant virus. Pathobiology (1992) 0.94
Restoration of cell surface CD4 expression in human immunodeficiency virus type 1-infected cells by treatment with a Tat antagonist. J Virol (1992) 0.94
Retroviral etiology of the acquired immune deficiency syndrome (AIDS). AIDS Res (1986) 0.94
Induction of dormant HIV-1 by sodium butyrate: involvement of the TATA box in the activation of the HIV-1 promoter. AIDS (1991) 0.94
Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro. J Virol (1997) 0.94
The redox state of cysteines in human immunodeficiency virus type 1 Vif in infected cells and in virions. Biochem Biophys Res Commun (1997) 0.93
Replication of different clones of human immunodeficiency virus type 1 in primary fetal human astrocytes: enhancement of viral gene expression by Nef. J Neurovirol (1999) 0.93
Contribution of multiple rounds of viral entry and reverse transcription to expression of human immunodeficiency virus type 1. A quantitative kinetic study. J Biol Chem (1991) 0.92
Production of infectious Epstein--Barr virus in mouse lymphocytes. Nature (1981) 0.91
Expression of the T4 molecule (AIDS virus receptor) by human brain-derived cells. FEBS Lett (1987) 0.90
A system for the high efficiency replication of HIV-1 in neural cells and its application to anti-viral evaluation. Virology (1992) 0.89
Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village. AIDS Res (1986) 0.88
Redefinition of tropism of common macrophage-tropic human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1995) 0.88
The establishment of rodent cell lines persistently producing HIV-1. Virology (1992) 0.87
Full-length CD4 electroinserted in the erythrocyte membrane as a long-lived inhibitor of infection by human immunodeficiency virus. Proc Natl Acad Sci U S A (1991) 0.87
Apolipoprotein E epsilon4 allele is a risk factor for late-onset Alzheimer's disease and vascular dementia in Han Chinese. Int J Geriatr Psychiatry (2001) 0.86
Generation of CD4+ and CD8+ T-cell clones from PBLs of HIV-1 infected subjects using herpesvirus saimiri. Nat Med (1996) 0.86
Uniform detection of HIV-1 in alveolar macrophages of pediatric but not adult AIDS patients. J Leukoc Biol (1993) 0.86
Effects of dietary glycyl-glutamine on growth performance, small intestinal integrity, and immune responses of weaning piglets challenged with lipopolysaccharide. J Anim Sci (2009) 0.86
Cloning of differentially expressed genes in an HIV-1 resistant T cell clone by rapid subtraction hybridization, RaSH. Gene (2001) 0.86
First observation of the M1 transition ψ(3686)→γη(c)(2S). Phys Rev Lett (2012) 0.86
The detection of Epstein-Barr virus receptors utilizing radiolabelled virus. J Gen Virol (1981) 0.86
The human immunodeficiency virus type 1 vif gene: the road from an accessory to an essential role in human immunodeficiency virus type 1 replication. Curr Top Microbiol Immunol (1995) 0.86
The interferon- and differentiation-inducible p202a protein inhibits the transcriptional activity of c-Myc by blocking its association with Max. J Biol Chem (2000) 0.86
Epstein-Barr virus co-reconstituted with Sendai virus envelopes infects Epstein-Barr virus-receptor negative cells. Biochim Biophys Acta (1981) 0.85
Observation of two new N* resonances in the decay ψ(3686)→ppπ0. Phys Rev Lett (2013) 0.85
Effect of dietary supplementation with glycitein during late pregnancy and lactation on antioxidative indices and performance of primiparous sows. J Anim Sci (2015) 0.85
Infection of mouse lymphocytes by Epstein-Barr virus. II. Stimulation of cellular DNA synthesis by EBV in the absence of EBNA induction and cell transformation. Virology (1984) 0.84
Calcium channel blockade and anti-free-radical actions of panaxatriol saponins in cultured myocardiocytes. Zhongguo Yao Li Xue Bao (1996) 0.84
Induction of Epstein-Barr virus in B-lymphoblastoid cells by human immunodeficiency virus type 1. Int J Cancer (1989) 0.84
Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors. AIDS Res Hum Retroviruses (2000) 0.83
Levels of effectiveness of gene therapies targeting survivin and its splice variants in human breast cancer cells. Drug Discov Ther (2011) 0.83
Peptide inhibitors of HIV-1 protease and viral infection of peripheral blood lymphocytes based on HIV-1 Vif. Proc Natl Acad Sci U S A (1998) 0.83
First observation of η(1405) decays into f(0)(980)π0. Phys Rev Lett (2012) 0.83
Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag. J Virol (2001) 0.83
A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells. J Virol (1996) 0.82
Epstein-Barr virus and chronic lymphadenomegaly in male homosexuals with acquired immunodeficiency syndrome (AIDS). AIDS Res (1986) 0.82
Isolation and long-term culture of primary ocular human immunodeficiency virus type 1 isolates in primary astrocytes. J Neurovirol (1997) 0.82
Role of Epstein-Barr virus in acquired immune deficiency syndrome. Adv Exp Med Biol (1985) 0.81
Low-cytopathic infectious clone of human immunodeficiency virus type I (HIV-I). FEBS Lett (1988) 0.81
Primary brain lymphoma in the immunocompetent host: relation to Epstein-Barr virus. Mod Pathol (1990) 0.80
Non-Hodgkin's lymphoma after treatment of Hodgkin's disease: association with Epstein-Barr virus. Ann Intern Med (1986) 0.80
Establishment of human glial cell lines chronically infected with the human immunodeficiency virus. Virology (1988) 0.80
Improvement of Herpesvirus saimiri T cell immortalization procedure to generate multiple CD4+ T-cell clones from peripheral blood lymphocytes of AIDS patients. J Immunol Methods (1997) 0.80
Expression of glial fibrillary acidic protein in human glioma cell lines as detected by molecular hybridization. Acta Neuropathol (1987) 0.80
Transfer of the Epstein-Barr virus (EBV) DNA fragment coding for EBNA-1, the putative transforming antigen of EBV, into normal human lymphocytes: gene expression without cell transformation. Biochem Biophys Res Commun (1986) 0.80
Genetic variability and function of the long terminal repeat from syncytium-inducing and non-syncytium-inducing human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1996) 0.80
Membranes of EBV-carrying virus nonproducer cells inhibit leukocyte migration of EBV-seropositive but not seronegative donors. J Immunol (1981) 0.80
Antagonistic effect of 3,6-dimethamidodibenzopyriodonium gluconate on lipid peroxidation in cerebral cortical neuronal cultures and rat brains during focal cerebral ischemia reperfusion. Acta Pharmacol Sin (2000) 0.80
Dependence of CD8+ T-cell-mediated suppression of HIV type 1 on viral phenotypes and mediation of phenotype-dependent suppression by viral envelope gene and not by beta-chemokines. AIDS Res Hum Retroviruses (2000) 0.80
Host cell range of adult T-cell leukemia virus. I. Viral infectivity and binding to various cells as detected by flow cytometry. Int J Cancer (1985) 0.79